InvestorsHub Logo
Followers 34
Posts 4311
Boards Moderated 0
Alias Born 07/16/2014

Re: KMBJN post# 10795

Wednesday, 11/02/2016 3:21:47 PM

Wednesday, November 02, 2016 3:21:47 PM

Post# of 16911
Thanks for the informative insights.

The end of the year is swiftly approaching, so I am looking forward to the upcoming announcement. It seems to me that they should be able to include the other drug in their repertoire if they so desired. Are you aware of the comparative preference rates between the two drugs?

LEGEND OF ABBREVIATIONS
B = Brilacidin, the antibiotic
K = Kevetrin, the oncology drug
P = Prurisol, the psoriasis drug
SAE = Serious Adverse Event
IND = Investigational New Drug


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TTNP News